Abstract:1026 Objectives: At present, triple-negative breast cancer (TNBC) has no specific molecular target. Cell-derived nanoparticles have been gaining increasingly attention due to their ability to mimic the properties of their source cells. Herein, we design a new platform of cancer cell membrane-coated up-conversion nanoparticles (CCm-UCNP) for homologous-targeting multi-modal imaging, including up-conversion luminescence imaging (UCL), magnetic resonance imaging (MRI) and positron emission tomography (PET) tumor imaging, for specific diagnosis and differential diagnosis of TNBC. Methods: Differential centrifugation was used to gain pure cancer cell membranes of MDA-MB-231 cells (CCm231), and coating up-conversion nanoparticles (UCNPs) by physical extrusion through a 400 nm porous polycarbonate membrane. The characterization was measured, and the protein expression before and after cancer cell membrane-coated was confirmed. Inserting 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-(polyethylene glycol)2000-Cy5 (DSPE-PEG-Cy5) into CCm231 to label nanoparticles, and homologous-targeting ability and immune evasion ability were observed through incubating Cy5-DSPE-PEG-CCm231-UCNPs with different kinds of breast cancer cells and Raw264.7 cells (a kind of mice macrophage) by confocal laser scanning microscope. CCK-8 assay was used to evaluate the cytotoxicity. CCm231-UCNPs and UCNPs were injected intravenously into MDA-MB-231 and MCF-7 tumor bearing mice for UCL and MRI respectively. 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[azido(polyethylene glycol)-2000] (DSPE-PEG-N3) was inserted into CCm231to react with DBCO by click chemistry for radiolabeling 18F used for PET imaging. N3-DSPE-PEG-CCm231-UCNPs were injected intravenously into MDA-MB-231 and MCF-7 tumor bearing mice of 24 h pre-positioning respectively, then DBCO-L-NETA-Al18F were injected, followed by serial PET imaging and ex vivo biodistribution study. For evaluating systematic toxicity, BALB/c-nu mice (n = 6) received injection of the same concentration of CCm231-UCNPs, UCNPs and CCm231, PBS were used as control. Results: Core-shell structure of CCm231-UCNPs of ~ 25 nm in size, with the similar protein profile before and after membrane-coated were successfully synthesized. The fluorescence signal of MDA-MB-231 group was extremely higher than those of other cell groups. Raw264.7 had nearly no uptake of Cy5-DSPE-PEG-CCm231-UCNPs, which exhibited immune evasion ability. No obvious cytotoxicity of CCm231-UCNPs had been observed. In the image of UCL and MRI, CCm231-UCNPs to MDA-MB-231 tumor group showed highest tumor site uptake, and the best imaging time was 24 h post-injection. Lower fluorescence signal of liver was observed compared to the group of UCNPs. As for PET imaging, N3-DSPE-PEG-CCm231-UCNPs to MDA-MB-231 tumor group showed highest tumor site uptake (6.39±1.12, 4.97±0.52, 4.70±0.9 and 4.05±0.5 %ID/g at 0.5, 1, 2 and 4h respectively) compared with those in MCF-7 tumor group (1.48±0.18, 1.16±0.10, 1.28±0.09 and 1.20±0.14 %ID/g at 0.5, 1, 2 and 4h respectively). Also, the liver and spleen were not visible. Neither death nor significant difference in body weight among four groups were observed after 30 days. Blood routine, hepatic and renal functions tests, and histology analysis suggested good biocompatibility of CCm231-UCNPs in vivo. Conclusions: We have successfully constructed CCm231-UCNPs, and the immune evasion ability and homologous targeting ability were confirmed by in vitro experiments and in vivo multi-modal imaging, including UCL, MRI and PET. No significant cytotoxicity and biological toxicity of these biomimetic nanoparticles were detected. Our study provides a new method for specific diagnosis and differential diagnosis of TNBC. Funding: This work was supported by the National Natural Science Foundation of China (No. 81630049, 81801738 and 81501532).

Cancer cell membrane-coated up-conversion nanoparticles for homologous-targeting multimodality imaging

Biomimetic Metallacage Nanoparticles with Aggregation-Induced Emission for NIR-II Fluorescence Imaging-Guided Synergistic Immuno-Phototherapy of Tumors

Red blood cell membrane-coated upconversion nanoparticles for pretargeted multimodality imaging of triple-negative breast cancer

Effective Cancer Targeting and Imaging Using Macrophage Membrane-Camouflaged Upconversion Nanoparticles.

Radiolabeled Human Protein-Functionalized Upconversion Nanoparticles for Multimodal Cancer Imaging

&Lt;p>cell Membrane Camouflaged Nanoparticles: a New Biomimetic Platform for Cancer Photothermal Therapy</p>

Biomimetic Upconversion Nanoparticles and Gold Nanoparticles for Novel Simultaneous Dual-Modal Imaging-Guided Photothermal Therapy of Cancer

Ultra-sensitive Nanoprobe Modified with Tumor Cell Membrane for UCL/MRI/PET Multimodality Precise Imaging of Triple-Negative Breast Cancer

Biomimetic nanobubbles for triple-negative breast cancer targeted ultrasound molecular imaging

Multifunctional and Multiplexed Nanoparticles for Molecular Imaging and Treatment of Breast Cancer

Cell membrane camouflaged biomimetic nanoparticles: Focusing on tumor theranostics

ICAM1-Targeting Theranostic Nanoparticles for Magnetic Resonance Imaging and Therapy of Triple-Negative Breast Cancer

Cancer Cell Membrane Biomimetic Nanosystem for Homologous Targeted Dual-Mode Imaging and Combined Therapy

Engineered Design of Theranostic Upconversion Nanoparticles for Tri-Modal Upconversion Luminescence/magnetic Resonance/x-Ray Computed Tomography Imaging and Targeted Delivery of Combined Anticancer Drugs

Peptide-enhanced tumor accumulation of upconversion nanoparticles for sensitive upconversion luminescence/magnetic resonance dual-mode bioimaging of colorectal tumors.

Generalized syntheses of tumor targeted yolk/shell structured multifunctional nanosystems

Enhanced Tumor-Accumulation of Upconversion Nanoparticles for Upconversion Luminescence/Magnetic Resonance Dual-Mode Bioimaging of Colorectal Tumor Using a Tumor Affinity Peptide with PSP Motif

Cancer cell membrane-coated magnetic nanoparticles for MR/NIR fluorescence dual-modal imaging and photodynamic therapy.

Preferential Cancer Cell Self-Recognition and Tumor Self-Targeting by Coating Nanoparticles with Homotypic Cancer Cell Membranes

Cancer Cell Membrane-Coated Upconversion Nanoprobes for Highly Specific Tumor Imaging.

Protein modified upconversion nanoparticles for imaging-guided combined photothermal and photodynamic therapy